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doi:10.1016/j.kjms.2011.06.003Abstract Cancer is one of the most common causes of morbidity and mortality. Genes whose
products play a critical role in regulation of the immune response include the HLA antigen and
cytokine families of genes. Oral cancer is common in men in developing countries, and its
frequency is increased by using betel-quid, tobacco, and alcohol. The association between
certain HLA Class I and Class II haplotypes and cancer has been documented in a variety of
tumors. There was no previous data concerning the association of specific HLA Class II
DQA1, DQB1 alleles, or haplotypes with oral cancer patients. In this study, we enrolled 134
Taiwanese patients with histologically confirmed oral cancer and 268 age- and gender-matched
healthy Taiwanese adults as control group to investigate the association between HLA-DQA1,
HLA-DQB1 allele frequencies and oral cancer patients by using polymerase chain reaction with
sequence-specific primers. We found that both HLA-DQA1* and HLA-DQB1* allele frequencies in
oral cancer patients revealed no significant difference from those of control groups. Haplotype
frequencies of HLA*DQA1-0103-DQB1*0601 in oral cancer patients were significantly lower than
those of the control group (odds ratio: 0.18, 95% confidence interval: 0.054e0.583, pcZ 0.02).
Our data suggest that HLA DQA1*0103-DQB1*0601 haplotype may be protective with regard to
the development of oral cancer.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100
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Cancer is one of the most common causes of morbidity and
mortality today, with more than 10 million new cases and
more than 6 million deaths each year worldwide. Tobacco
and alcohol are regarded as the major risk factors for oral
cancer [1]. Oral and pharyngeal cancer ranked the sixth
most common cancer in the world. It is estimated that
about 43% of cancer deaths are because of tobacco use,
unhealthy diets, alcohol consumption, inactive lifestyles,
and infection. Low-income and disadvantaged groups are
generally more exposed to avoidable risk factors, such as
environmental carcinogens, alcohol, infectious agents, and
tobacco use. Oral cancer is a serious and growing problem
in many parts of the globe [2]. In 2008, oral cancer was
ranked the sixth cause (9.6%) of death in Taiwan. For males
only, oral cancer was ranked the fourth cause (17.9%) of
death. Since 1986, oral cancer as a cause of death has
increased 3.32-fold.
It has been estimated that 2e2.8 million people have the
habit of betel-quid chewing in Taiwan. Ko et al. [3] repor-
ted that the incidence of oral cancer in Taiwan has been
computed to be 123 times higher in patients who smoke,
drink alcohol, and chew betel-quid than in abstainers.
Although tobacco and alcohol consumption are the major
risk factors for oral squamous cell carcinoma, there are
individual variations in genetic susceptibility. One study
demonstrated that the high incidence of autoantibodies in
oral submucous fibrosis (OSF) patients might be because of
betel-quid chewing habit, toxic betel-quid ingredients, and
genetic susceptibility of the OSF patients [4]. Chen et al.
[5] found a significant increase in the frequency of HLA-B76
and haplotype HLA-B48/Cw7, B51/Cw7, and B62/Cw7 in
OSF patients.
The development of cancer is a multistep process that is
characterized by the accumulation of genetic alterations
in cells and changed cellular interactions with the
surrounding healthy tissues. The human immune system is
believed to be intrinsically involved in this process [6]. The
HLA system is encoded on the short arm of chromosome 6
and falls into two classes, HLA-class I and HLA-class II,
which are structurally and functionally different [7]. Each
individual inherits specific combinations of HLA alleles
known as haplotypes [8]. The correlation of certain HLA-
class I and HLA class-II haplotypes with tumorigenesis has
been documented in a variety of tumors [6,9e12]. Kubler
et al. [6] observed a significantly increased incidence of
the HLA haplotypes DRB1*0301-DQA1*0501-DQB1*0201 and
DRB1*1001-DQA1*0101-DQB1*0501 in the ovarian cancer
patients and they suggested that HLA class II loci or indi-
vidual HLA class haplotypes may be involved in the patho-
genesis of ovarian cancer. Koskinen et al. [13] and Reinders
et al. [14] demonstrated the association of HLA DRB1, DQB1
and head-neck squamous cell carcinoma patients. However,
to date, there exist no data concerning the association of
specific HLA-class II DQA1, DQB1 alleles with oral cancer
patients. The aim of this study is to compare HLA-class II
DQA1, DQB1 allele and haplotypes frequencies between oral
cancer patients and healthy control groups in Taiwan,
focusing on the potential contribution of HLA-Class -II alleles
in the development of oral cancer.Methods
Patients
We investigated 134 Taiwanese patients with histologically
confirmed oral cancer treated at the Department of Surgical
Oncology or Department of Oncology Center, Kaohsiung
Medical University Hospital. The mean age of cancer
patients was 50.3 3.2 years old. The male:female ratio
was 130:4. Two hundred sixty-eight age- and gender-
matched healthy Taiwanese adults from the local pop-
ulation (unrelated individuals, with no history of betel-quid
chewing and without cancer history, mean age: 50.2 13.9,
pZ 0.227; male:female ratio was 252:16, pZ 0.194) were
included as a control group.
Informed consent was obtained from all participants
and the research protocol was approved by The Ethics
Committee of Kaohsiung Medical University (KMUH-IRB-
950155). For HLA typing, 5 mL blood samples were taken
from each patient in sterile vacutainer tubes containing
EDTA anticoagulant. Samples were stored at room
temperature until DNA extraction.
HLA typing
The QIAamp spin column was carefully opened and another
500 mL of wash buffer AW were added. This solution was
centrifuged at 8000 revolutions per minute for 1 minute and
at full speed for a further 2 minutes. The QIAamp spin
column was placed in a clean 1.5 mL microfuge tube and
the collection tube containing the filtrate was discarded.
The QIAamp spin column was carefully opened and the DNA
was subsequently eluted with 200 mL of elution buffer AE
preheated to 70C. This solution was incubated at room
temperature for 1 minute and then centrifuged at 8000
revolutions/min for 1 minute.
HLA genotyping
HLA-DQA1 and HLA-DQB1 typing were performed by using
polymerase chain reaction (PCR) amplification with
sequence-specific primer (SSP) methods [15]. Briefly, 10
primer pairs were used to determine DQA1 alleles and 22
primer pairs to identify most of the DQB1 alleles. As
a matter of convenience, the 22 primer pairs used were
divided into 14 primer pairs as the first set and 8 primer
pairs as the second set.
All PCR amplifications were performed on 75 ng genomic
DNA in 10 mL reaction mixtures containing PCR buffer (10
high magnesium buffer: 500 mM Tris-HCL, pH 8.3, 2.5 mg/mL
bovine serum albumin, and 30 mM MgCl2); 2 mM each of
dATP, dTTP, dGTP, and dCTP (10 dNTP); 0.25 mM of the
allele- and group-specific DQA1 and DQB1 primers; 0.05 mM
of the internal control primer; and diluted Taq DNA poly-
merase (1:10). The 30 amplification cycles were performed
in an air thermal cycler (Idaho Technology, Salt Lake City,
UT, USA). Each cycle comprised denaturation at 94C for
30 seconds, annealing at 64C for 30 seconds, and extension
at 72C for 30 seconds. Absence or presence of PCR products
was visualized by agarose gel electrophoresis.
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Strength of the statistical association between the disease
and genetic markers was expressed by odds ratio (OR). For
each allele or genotype, whether structural or functional,
the Chi-square or Fisher’s exact probability test was used
where appropriate to compare the differences in the
frequencies between the cancer and control group. The p
values were corrected for the number of different alleles
tested (pc). Statistical significance was defined as p value
less than 0.05. Data analysis was performed using the SPSS
12.0 statistical package for Windows (SPSS, Inc., Chicago,
IL, USA).
Results
Patient characteristics
The distribution of cancer sites in our cancer patients were
as follows: mouth 47 cases (labial mucosa 25, gingiva 9,
palate 8 and floor of mouth 5, 35.1%), buccal mucosa 51
cases (38.1%), and tongue 36 cases (27.9%), respectively.
Histology findings in cancer patients included conventional
squamous cell carcinoma (92.5%) and verrucous carcinoma
(7.5%). Ninety-six percent of oral cancer patients had
a history of betel-quid chewing. The duration of betel-quid
chewing by our cancer patients was distributed as follows:
3e5 years (20.8%), 6e10 years (37.5%), 11e30 years (33.3%),
and more than 30 years (8.3%), respectively.
Table 1 shows the association of allele frequencies of
HLA DQA1 between cancer patients and control group. The
table reveals that there was no significant difference in HLA
DQA1 allele frequencies between oral cancer patients and
control groups after correction. There was also no signifi-
cant difference of HLA-DQB1 allele frequencies between
cancer patients and control groups after correction
(Table 2).
Haplotypes based on inferred linkages of HLA-DQA1 and
HLA-DQB1 alleles are shown in Table 3. This table reveals
that only 3 of 134 cancer patients (1.11%) have inherited
the HLA haplotype DQA1-0103, DQB1-0601, whereas among
the control group, 5.97% have inherited this haplotype.
Haplotype frequency of HLA*DQA1-0103-DQB1*0601 in the
patient group was significantly lower than that of theTable 1 HLA-DQA1* allele frequencies in oral cancer patients a
Allele Oral cancer (nZ 268), n (%) Control (nZ 536), n
DQA1*0101 11 (4.10) 15 (2.80)
DQA1*0102 24 (8.96) 77 (14.37)
DQA1*0103 30 (11.20) 88 (16.42)
DQA1*0104 27 (10.07) 30 (5.60)
DQA1*0201 3 (1.12) 6 (1.12)
DQA1*0301 78 (29.10) 120 (22.39)
DQA1*0302 25 (9.33) 60 (11.20)
DQA1*0401 13 (4.86) 26 (4.85)
DQA1*0501 41 (15.30) 85 (15.86)
DQA1*0601 16 (5.97) 29 (5.41)
Fisher’s exact testdNSZ nonsignificant; pcZ corrected p value.control group (OR: 0.18, 95% confidence interval: 0.054e
0.583, pcZ 0.02).
There were no significant differences of allele frequen-
cies of DQA1 and DQB1 between oral cancer patients
(cancer site at the mouth, buccal mucosa, and tongue,
respectively) and control groups (data not shown).Discussion
Peptides of the appropriate shape and charge are able to
bind within a groove of the major histocompability complex
(MHC) molecule. The MHC molecules are highly poly-
morphic, but each individual will express one maternal and
one paternal allele of HLA Class I molecule A, B, and C and
HLA Class II DR, DP, and DQ. As a result of T-cell receptor
specificity and MHC restriction, a clone of T-cells will bear
a specific receptor, which has a very limited repertoire of
targets (peptide-MHC complexes) [16]. To our knowledge,
this is the first study to investigate the association between
HLA-DQA1, HLA-DQB1 alleles and oral cancer patients in
literature. We found that the haplotype *DQA1-0103-
DQB1*0601 frequency in the patient group was signifi-
cantly lower than that of the control group, and our data
suggest that haplotype *DQA1-0103-DQB1*0601 may be
protective with regard to the development of oral cancer.
With regard to the same haplotype, DQA1*0103-DQB1*0601,
Kawahara et al. [17] obtained results that differed in that
the patients with mucosa-associated lymphoid tissue
lymphoma showed significantly increased incidence of the
haplotype DQA1*0103-DQB1*0601. Thus, the real role of
HLA class II DQA1, DQB1 in malignant tumorigenesis needs
further investigation.
With regard to the haplotype DQA1*0501-DQB1*0201,
the haplotype frequency in our oral cancer patients
revealed no significant difference from that of the control
group, whereas Kubler et al. [6] demonstrated a signifi-
cantly increased frequency of the haplotype DRB1*0301-
DQA1*0501-DQB1*0201 in ovarian cancer patients
(p< 0.001). Kubler et al. [6] suggested that DRB1 gene
locus plays a central role in the immune system by pre-
senting peptides derived from extracellular proteins. HLA-
DRB1 belongs to the HLA class II beta-chain paralogs. The
class II molecule is a heterodimer consisting of an alpha and
a beta chain, both anchored in the membrane. Class IInd comparison with control groups
(%) Odds ratio 95% Confidence interval p pc
0.673 0.305e1.485 0.324 NS
1.706 1.051e2.767 0.029 0.29
1.558 1.000e2.427 0.048 0.48
0.529 0.308e0.910 0.020 0.20
1.000 0.248e4.030 1.000 NS
0.703 0.504e0.980 0.037 0.37
1.225 0.749e2.003 0.417 NS
1.000 0.505e1.979 1.000 NS
1.043 0.696e1.565 0.837 NS
0.901 0.480e1.689 0.745 NS
Table 2 HLA-DQB1* allele frequencies in oral cancer patients and comparison with control groups
Allele Oral (nZ 268), n (%) Control (nZ 536), n (%) Odds ratio 95% Confidence interval p pc
DQB1*0201 16 (5.97) 54 (10.07) 1.765 0.990e3.146 0.052 0.52
DQB1*0301 36 (13.43) 65 (12.13) 0.889 0.575e1.376 0.598 NS
DQB1*0302 21 (7.84) 50 (9.33) 1.210 0.711e2.060 0.482 NS
DQB1*0303 76 (28.36) 112 (20.90) 0.667 0.476e0.935 0.018 0.18
DQB1*0304 0 (0) 1 (0.19) 1.002 0.998e1.006 1.000 NS
DQB1*0401 24 (8.96) 36 (6.72) 0.732 0.427e1.254 0.255 NS
DQB1*0402 2 (0.75) 12 (2.24) 3.046 0.677e13.708 0.159 NS
DQB1*0501 5 (1.87) 19 (3.54) 1.933 0.714e5.235 0.187 NS
DQB1*0502 22 (8.21) 44 (8.21) 1.000 0.586e1.706 1.000 NS
DQB1*0503 10 (3.73) 10 (1.87) 0.490 0.202e1.193 0.109 NS
DQB1*0601 42 (15.67) 95 (17.72) 1.159 0.779e1.724 0.466 NS
DQB1*0602 5 (1.87) 24 (4.48) 2.466 0.930e6.536 0.061 NS
DQB1*0603 0 (0) 0 (0) d d d NS
DQB1*0604 9 (3.36) 14 (2.61) 0.772 0.330e1.807 0.550 NS
Fisher’s exact testdNSZ nonsignificant; pcZ corrected p value.
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including B-lymphocytes, dendritic cells, and macro-
phages. Kubler et al. [6] hypothesized that these HLA
alleles differed in their ability to present tumor antigens in
the disease setting and thus influenced antitumoral immu-
nity. The role of DRB1, DQA1, and DQB1 in the interaction of
viruses, betel nuts, and carcinogens is still not very clear.
Chen et al. [9] demonstrated that some Taiwanese betel-
quid chewers with particular HLA phenotypes and haplo-
types are prone to develop OSF. In addition, some particular
HLA haplotypes may play more important roles than indi-
vidual HLA phenotypes for the genetic susceptibility to OSF
[5]. Our previous studies revealed that the HLA-DQA1 and
HLA-DQB1 allele frequencies in breast cancer patients
showed no significant differences from those of controlTable 3 HLA-DQA1*HLA-DQB1* haplotype in oral cancer patient
Haplotype Patient (nZ 268), n (%) Cont
DQA1-0102-DQB1-0201 0 (0)
DQA1-0102-DQB1-0303 8 (2.96)
DQA1-0102-DQB1-0601 3 (1.11)
DQA1-0102-DQB1-0602 0
DQA1-0103-DQB1-0201 2 (0.74)
DQA1-0103-DQB1-0303 8 (2.96)
DQA1-0103-DQB1-0601 3 (1.11)
DQA1-0103-DQB1-0602 0 (0)
DQA1-0104-DQB1-0201 0 (0)
DQA1-0104-DQB1-0303 6 (2.22)
DQA1-0104-DQB1-0601 5 (1.85)
DQA1-0104-DQB1-0602 0 (0)
DQA1-0301-DQB1-0303 17 (6.30)
DQA1-0301-DQB1-0201 6 (2.22)
DQA1-0301-DQB1-0601 14 (5.19)
DQA1-0301-DQB1-0602 2 (0.74)
DQA1-0501-DQB1-0201 2 (0.74)
DQA1-0501-DQB1-0303 13 (4.81)
DQA1-0501-DQB1-0601 4 (1.48)
DQA1-0501-DQB1-0602 0 (0)
Fisher’s exact testdNSZ nonsignificant; pcZ corrected p value.groups. Although Cantu de Leon et al. [18] observed that
DRB1*1301 was a susceptibility allele and DRB1*1602 was
a protective allele in breast cancer patients, they also found
that HLA-DQ*0301 allele was much more common in the
control group and could be protective with regard to
the disease (OR: 0.078; pZ 0.00001). Their results revealed
the role of the MHC genes in the pathophysiology of breast
cancer, suggesting that there existed a disorder of immune
regulation in the development of breast cancer. The trig-
gering factor of tumorigenesis seems to be restricted to
certain ethnic groups and certain geographical regions
because the relevant MHC alleles are highly diverse. Hilde-
sheim et al. [11] also reported that the extended haplotype
HLA-A*3303-B*5801/2-DRB1*0301-DQB1*0201/2-DPB1*0401,
specific to the Chinese ethnic group, was associated withs and comparison with control groups
rol (nZ 536), n (%) Odds ratio p pc
5 (0.93) 0.99 0.175
12 (2.24) 1.33 0.533 d
17 (3.17) 0.34 0.076 d
3 (0.56) 0.99 0.555 d
4 (0.75) 0.99 1 d
18 (3.36) 0.88 0.764 d
32 (5.97) 0.18 0.001 0.02
7 (1.31) 0.99 0.102 d
3 (0.56) 0.99 0.555 d
4 (0.75) 3.02 0.093 d
3 (0.56) 3.35 0.126 d
0 (0) d NS d
33 (6.16) 1.02 0.938 d
9 (1.68) 1.33 0.59 d
15 (2.80) 1.9 0.086 d
7 (1.31) 0.56 0.725 d
16 (2.99) 0.24 0.042 0.84
17 (3.17) 1.54 0.245 d
9 (1.68) 0.88 1 d
3 (0.56) 0.99 0.555 d
HLA-DQA1, HLA-DQB1 and oral cancer 445a significantly increased risk of nasopharyngeal cancer.
There is a close relationship between oral squamous cell
carcinoma and betel-quid use, a habit of about 20% of the
world’s population [19]. The International Agency for
Research on Cancer has declared that betel-quid is carci-
nogenic to humans and that has been confirmed [20]. Betel-
quid chewing is the main cause of OSF, leukoplakia, and oral
cancer [21]. Lee et al. [22] found that betel-quid chewing
was strongly associated with all these oral diseases, the
attributable fraction of oral leukoplakia being 73.2% and of
OSF 85.4%. Factors other than betel-quid chewing might
play a role in the development of oral precancerous diseases
in populations. Shiu et al. [23] reported that elimination of
betel nuts may prevent 62% of leukoplakia and 26% of
malignant transformation to oral carcinoma in the general
population. In our study, 96% of cancer cases had the habit
of betel-quid chewing.
In summary, the haplotype *DQA1-0103-DQB1*0601
frequencies in our patient group were significantly lower
than those of the control group; thus, HLA*DQA1-0103-
DQB1*0601 could be protective with regard to the devel-
opment of oral cancer. Our data revealed the possible role
of the MHC genes in the pathogenesis of oral cancer, sug-
gesting that there exists a disorder of immune regulation in
the development of oral cancer.
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